Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics
2005 NIDA Genetics Portfolio (Human Genetics)
NIDA Genetics Programs
 
Return to Home Page
About Genetics Workgroup
Human Genetics Application Guidelines
NIDA Genetics News
NIDA Genetics Consortium
NIDA Recent Findings
NIDA Genetics Portfolio
NIDA Initiatives in Genetics
NIDA Meetings
NIDA Program Contacts
 

Resources for Genetics, Cell Biology, and Neuroscience
 
Calendar
Human Genetics
Tissue and Cell Repositories
Twin Registry
Nucleotide
Gene Expression
Genomes
Proteins
Model Organisms
Mouse
Knowledgebase for Addiction Related Genes (KARG)
Cell Biology
SfN Neuroscience Database
Gateway
Bibliographic Resources
 

Main Portfolio Index > 2005 Genetic Index > HUMAN GENETICS PORTFOLIO

NIDA HUMAN GENETICS Portfolio Listing A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 
*
ANDREASEN, NANCY C Research Training: Major Psychoses/Clinical Neurobiology
  5T32MH019113-15
   
ANOKHIN, ANDREY P. BIOBEHAVIORAL MARKERS OF RISK FOR NICOTINE ADDICTION
  5K01DA000421-05
   
ANOKHIN, ANDREY P. Neurocognition, Genetics, and Adolescent Substance Abuse
  5R01DA018899-02
   
ARNDT, STEPHAN V. Gene-Environment Interaction in Etiology of Drug Abuse
  5R01DA005821-15

Back to previous page


 
*
BAUER, LANCE O Genetic Versus Phenotypic Markers of Relapse Risk
  1R01DA017666-01A2
   
BEGLEITER, HENRI COLLABORATIVE STUDY ON THE GENETICS OF ALCOHOLISM/COGA
  5U10AA008401-17
   
BENOWITZ, NEAL L Pharmacogenetics of Nicotine Addiction and Treatment
  1U01DA020830-01
   
BIERUT, LAURA J The Collaborative Genetic Study of Nicotine Dependence
  5P01CA089392-05
   
BLACK, DONALD W Family-Genetic Study of Pathological Gambling
  1R01DA021361-01A1
   
BUCHOLZ, KATHLEEN K. Gene-Enviroment in Outcomes of PSuD Twins' Offspring
  5R01DA014363-05

Back to previous page


 
*
CINCIRIPINI, PAUL M Pharmacogenetics, Emotional Reactivity & Smoking(RMI)
  3R01DA017073-02S1
   
CINCIRIPINI, PAUL M Pharmacogenetics, Emotional Reactivity & Smoking
  5R01DA017073-02
   
COLLINS, ALLAN C Research Training-Genetics of Substance Abuse
  5T32DA017637-02
   
COTTLER, LINDA B T32: Drug Abuse Comorbidity, Prevention & Biostatistics
  5T32DA007313-07
   
CROWLEY, THOMAS J Antisocial Drug Dependence: Genetics
  3P60DA011015-08S1
   
CROWLEY, THOMAS J Antisocial Drug Dependence: Genetics
  5P60DA011015-08
   
CROWLEY, THOMAS J GENETICS OF ADOLESCENT ANTISOCIAL DRUG DEPENDENCE
  5R01DA012845-05
   
CRYSTAL, HOWARD A Substance Abuse and HIV: Genetics & Disease Progression
  1R01MH076537-01
   
CUBELLS, JOSEPH F Human Genetics of Drug-Abuse Related Phenotypes
  5K02DA015766-03

Back to previous page


 
*
DAHL, RONALD E. Pubertal Maturation & Drug Use Vulnerability
  5K08DA014276-02
   
DAVID, SEAN P Psychobiological /Genetic Determinants-Smoking Cessation
  5K08DA014276-04

Back to previous page


 
*
ESCAMILLA, MICHAEL A US/Costa Rica Psychiatric Genetic Research Training
  5D43TW006152-04
   
ESPY, KIMBERLY A Prenatal Tobacco Exposure: Perinatal and Genetic Risks
  3R01DA014661-03S1
   
ESPY, KIMBERLY A Prenatal Tobacco Exposure: Perinatal and Genetic Risks
  5R01DA014661-03
   
ESPY, KIMBERLY A Prenatal Tobacco Exposure: Perinatal and Genetic Risks
  7R01DA014661-04

Back to previous page


 
*
FARAONE, STEPHEN V Validating Novel Familial Phenotypes of Drug Abuse
  5R01DA018659-02
   
FOWLER, JOANNA S Role of Genotype and Maternal Smoking on Brain MAO A
  1K05DA020001-01

Back to previous page


 
*
GELERNTER, JOEL E Genetics of Opioid Dependence
  2R01DA012690-06
   
GELERNTER, JOEL E GENETICS OF COCAINE DEPENDENCE
  3R01DA012849-05S1
   
GELERNTER, JOEL E Thai-US Drug Dependence Genetics Research Training Grant
  5D43TW006166-04
   
GELERNTER, JOEL E Approaches to the Genetics of Substance Dependence
  5K24DA015105-03
   
GRUCZA, RICHARD A Longitudinal Studies in Personality and Substance Abuse
  5K01DA016618-03

Back to previous page


 

*
HASIN, DEBORAH S Alcohol in Israel: Genetic and Environmental Effects
  5R01AA013654-03
   
HASIN, DEBORAH S Phenotypes for Drug Abuse:Epidemiologic-Genetic Approach
  5R01DA018652-02
   
HATSUKAMI, K DOROTHY Tobacco Exposure Reduction
  5P50DA013333-07
   
HEITZEG, MARY M Longitudinal fMRI Study of Youth at Risk for Drug Abuse
  1K01DA020088-01
   
HOIDAL, JOHN R GENETICS AND CONSEQUENCES OF NICOTINE ADDICTION
  5P01HL072903-04
   
HOPFER, CHRISTIAN J A family study of substance use & coonduct disorder
  5R01DA015522-03
   
HOXIE, JAMES A Center For AIDS Research
  5P30AI045008-07
   
HUTCHISON, KENT E Progression of Craving and Addiction: Genetic Factors
  5R01DA014642-05


Back to previous page


 
*
IACONO, WILLIAM G Twin Family Study of Vulnerability to Substance Abuse
  5R01DA005147-18

Back to previous page


 
*

No Names at this time.

Back to previous page


 
*
KANDEL, DENISE B Epidemiological/Familial Aspects of Drug Use
  5K05DA000081-25
   
KENDLER, KENNETH S A Twin-Family Study of Drug Use, Abuse, and Dependence
  2R01DA011287-06
   
KHARASCH, EVAN D Opioids in Cancer Pain & Drug Abuse: Optimizing Therapy
  2K24DA000417-06
   
KHARASCH, EVAN D Opioids in Cancer Pain & Drug Abuse: Optimizing Therapy
  7K24DA000417-07
   
KIRISCI, LEVENT Quantifying and Tracking Risk for Substance Use Disorder
  1K02DA017822-01A1
   
KNOPIK, VALERIE S Externalizing Behavior: Genetics x Prenatal Nicotine
  5K01DA017671-03
   
KOSTEN, THOMAS R Comorbidity in  Cocaine and Opioid Pharmacotherapy
  2K05DA000454-06
   
KOSTEN, THOMAS R Cocaine Pharmacotherapy Targeting Dopamine & GABA
  3P50DA018197-02S1
   
KOSTEN, THOMAS R Cocaine Pharmacotherapy Targeting Dopamine & GABA
  5P50DA018197-02
   
KREEK, MARY J TREATMENT OF ADDICTIONS--BIOLOGICAL CORRELATES
  3P60DA005130-19S1
   
KREEK, MARY J Addictive Drugs-Pharmacology & Physiology
  5K05DA000049-28
   
KREEK, MARY J TREATMENT OF ADDICTIONS--BIOLOGICAL CORRELATES
  5P60DA005130-19

Back to previous page


 
*
LACHMAN, HERBERT M GENOME-WIDE ANALYSIS FOR ADDICTION SUSCEPTIBILITY GENES
  5R01DA012853-05
   
LERMAN, CARYN E Pharmacogenetic Investigation of Naltrexone (RMI)
  3R01DA017555-03S1
   
LERMAN, CARYN E Transdisciplinary Tobacco Use Research Centers
  5P50CA084718-08
   
LERMAN, CARYN E Pharmacogenetic Investigation of Naltrexone
  5R01DA017555-03
   
LI, MING D MAPPING OF SUSCEPTIBILITY LOCI FOR NICOTINE DEPENDENCE
  3R01DA012844-05S1
   
LIMACHER, MARIAN C. Advanced Postgraduate Program in Clinical Investigation
  9K30RR022258-07
   
LOFFREDO, CHRISTOPHER A Egypt Smoking Prevention Research Initiative
  7R01TW005944-04
   
LYNSKEY, MICHAEL T Cannabis and Other Illicit Drug Use: A Twin Study
  1R01DA018267-01A1
   
LYNSKEY, MICHAEL T Cannabis Use, Abuse and Dependence: Exploring Phenotypes
  5R01DA018660-02

Back to previous page


 

*
MEISCH, RICHARD A Drug Reinforcing Effects
  5K05DA000159-14

Back to previous page


 
*
NAIR, MADHAVAN P Cocaine in the Immuno and Neuropathogenesis of HIV-1 Infection
  3R01DA012366-07S1
   
NAIR, MADHAVAN P Cocaine/Immuno and Neuropathogenesis of HIV-1 Infection
  5R01DA012366-07
   
NEALE, MICHAEL C. Psychometric and Genetic Assessments of Substance Use
  5R37DA018673-02
   
NELSON, ELLIOT C Opioid Dependence: Candidate Genes and G x E Effects
  5R01DA017305-03
   
NICKERSON, DEBORAH A STARNET: Research Experiences for Students & Teachers
  2R25DA013180-06

Back to previous page


 
*
O'BRIEN, CHARLES P Center for Research Improving Treatment of Drug Abuse
  3P60DA005186-19S1
   
O'BRIEN, CHARLES P Center for Research Improving Treatment of Drug Abuse
  5P60DA005186-19

Back to previous page


 
*
PERGADIA, MICHELE L Refining Phenotypic Measures of Nicotine Withdrawal
  1K08DA019951-01
   
PHILIBERT, ROBERT A Genetic Studies of Substance Abuse in Iowa Adoptees
  5R01DA015789-02
   
POMERLEAU, OVIDE F Effects of family smoking history in never-smokers
  5R01DA014662-04
   
POMERLEAU, OVIDE F Candidate Genes for Smoking In Related and Unrelated Individuals
  5R01DA017640-03

Back to previous page


 
  No Names at this time

Back to previous page


 
*
REISS, DAVID The Early Growth and Development Study
  5R01HD042608-04
   
RHEE, SOO H Causes of Comorbidity:Substance Use Disorder, ADHD & CD
  5K01DA013956-05

Back to previous page


 
*
SACCONE, NANCY L Quantitative Analysis Methods for Complex Trait Genetics
  5K01DA015129-04
   
SADEE, WOLFGANG Polymorphisms in Regulatory Regions of Addiction Genes
  5R21DA018744-02
   
SAKAI, JOSEPH T Asian Teens, substance dependence and conduct disorder
  5K08DA016314-02
   
SINHA, RAJITA SCOR Application on Sex, Stress, and Cocaine Addiction
  5P50DA016556-04
   
SIPE, JACK C FAAH GENE MUTATIONS: RISK FACTORS IN DRUG USE/ADDICTION
  5R01DA015749-02
   
SIREVAAG, ERIK J Behavioral Genetics of Nicotine Dependence
  5R01DA014374-05
   
SMELSON, DAVID A Cue-Elicited Craving /Genetics in Relapse in Cocaine Use
  1R03DA020434-01
   
STEFANSSON, KARI A Genes contributing to nicotine dependence in humans
  1R01DA017932-01A1
   
STEINER, REBECCA C Molecular Basis of Nicotine Reinforcement in the Mouse
  1F31DA019298-01
   
SWAN, GARY E Biometric and Measured Genetic Research on Smoking
  5R01DA018019-03

Back to previous page


 
*
TARTER, RALPH E Drug Abuse Vulnerability: Mechanisms and Manifestations
  5P50DA005605-15
   
TEICHER, MARTIN H Early Stress, PTSD, and the Neurobiology of Addiction
  5R01DA017846-02
   
THOMAS, DAVID L HIV HCV Coinfection Antiviral Therapy and Fibrosis
  2R01DA013806-06
   
TSUANG, MING T MOLECULAR GENETICS OF HEROIN DEPENDENCE
  5R01DA012846-05
   
TSUANG, MING T Alternate Phenotypes of Substance Abuse
  5R01DA018662-02

Back to previous page

 
* No names at this time.

Back to previous page


 
*
VANYUKOV, MICHAEL M Phenogenetics of Liability to Substance Use Disorders
  1K02DA018701-01A1
   
VANYUKOV, MICHAEL M Substance Use Disorder Liability: Candidate Gene System
  3R01DA019157-02S1
   
VANYUKOV, MICHAEL M Substance Use Disorder Liability: Candidate Gene System
  5R01DA019157-02

Back to previous page


 
*
WALKER, BRUCE D The impact of HIV viral diversity and cellular immunity on HIV pathogenesis
  3P30AI060354-02S2
   
WALKER, BRUCE D Harvard Medical School Center for AIDS Research
  5P30AI060354-02
   
WIGDAHL, BRIAN L High Specificity HIV-1 Markers Predictive of Neuro-AIDS
  5R01DA019807-02

Back to previous page


 
* No Names at this time.

Back to previous page


 
*
YU, LEI Opioid Receptor Polymorphism & PD Drug Response
  5R01DA013471-05

Back to previous page


 
*
ZHANG, HEPING Methodological Research on Substance Use
  5K02DA017713-02
   
ZHANG, HEPING Statistical Methods in Genetic Studies of Substance Use
  5R01DA016750-02
   
ZUBIETA, JON-KAR Neurochemical Endophenotype Responses to Pain-Stress
  5R01DA016423-02

Back to previous page


 
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Return to top
 
 
 
 
Any questions or concerns regarding the genetics programs please contact Jonathan D. Pollock Ph.D. (301) 443-1887 or jp183r@nih.gov


NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Tuesday, March 11, 2008. The U.S. government's official web portal